Roon
+50%
est. 2Y upside i
Roon is a Sequoia-backed company since Arc Americas 2022.
Rank
#972
Sector
Digital Health
Est. Liquidity
~3Y
Data Quality
Data: LowRoon is a pre-revenue digital health startup with a $68M Series A valuation, but the round is over 18 months old.
Last updated: July 19, 2026
Roon achieves strong traction with $20M revenue, leading to a 4x exit at $272M. After preference, common upside is 385% net of 15% dilution, driven by AI differentiation and partnerships.
Moderate growth to $10M revenue, exit at $100M (1.5x entry). Common yields 55.3% net of dilution as convergence to comp multiples is limited by pre-revenue status.
Exit below $22.5M preference, common stock recovers nothing, resulting in -100% return due to high leverage and lack of revenue.
Preference Stack Risk
highFunding Intensity
33%Total funding of $22.5M represents 33% of current valuation, creating high preference overhang.
Dilution Risk
moderateExpected additional fundraising within 2 years may cause 15-25% dilution.
Secondary Liquidity
noneNo secondary transactions reported; valuation based on stale round.
Questions to Ask at the Interview
Strategic questions based on Roon's data — designed to show you've done your homework.
- 1
“What is the specific monetization strategy and timeline to revenue?”
- 2
“How does Roon plan to differentiate and compete against entrenched incumbents like Google and Doximity?”
- 3
“What is the expected timeline to liquidity, and what are the likely exit paths (acquisition vs IPO)?”
Community
Valuation Sentiment
Our model estimates +50% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.